Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Open Access
- 6 April 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 46 (5), 451-456
- https://doi.org/10.1038/ng.2936
Abstract
Cynthia Hawkins, Oren Becher and colleagues report the identification of recurrent mutations in ACVR1 in 20% of diffuse intrinsic pontine gliomas. Diffuse intrinsic pontine glioma (DIPG) is a fatal brain cancer that arises in the brainstem of children, with no effective treatment and near 100% fatality. The failure of most therapies can be attributed to the delicate location of these tumors and to the selection of therapies on the basis of assumptions that DIPGs are molecularly similar to adult disease. Recent studies have unraveled the unique genetic makeup of this brain cancer, with nearly 80% found to harbor a p.Lys27Met histone H3.3 or p.Lys27Met histone H3.1 alteration. However, DIPGs are still thought of as one disease, with limited understanding of the genetic drivers of these tumors. To understand what drives DIPGs, we integrated whole-genome sequencing with methylation, expression and copy number profiling, discovering that DIPGs comprise three molecularly distinct subgroups (H3-K27M, silent and MYCN) and uncovering a new recurrent activating mutation affecting the activin receptor gene ACVR1 in 20% of DIPGs. Mutations in ACVR1 were constitutively activating, leading to SMAD phosphorylation and increased expression of the downstream activin signaling targets ID1 and ID2. Our results highlight distinct molecular subgroups and novel therapeutic targets for this incurable pediatric cancer.This publication has 31 references indexed in Scilit:
- Savant Genome Browser 2: visualization and analysis for population-scale genomicsNucleic Acids Research, 2012
- Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinomaActa Biochimica et Biophysica Sinica, 2012
- BMP signaling is responsible for serum-induced Id2 expressionBiochemical and Biophysical Research Communications, 2012
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- ID2: A negative transcription factor regulating oligodendroglia differentiationJournal of Neuroscience Research, 2012
- Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine GliomaJournal of Clinical Oncology, 2011
- Natural genetic variation caused by small insertions and deletions in the human genomeGenome Research, 2011
- Molecular Consequences of the ACVR1R206H Mutation of Fibrodysplasia Ossificans ProgressivaOnline Journal of Public Health Informatics, 2010
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult DiseaseJournal of Clinical Oncology, 2010